66 related articles for article (PubMed ID: 25691294)
1. p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ.
Ma L; Liu J; Zhang X; Qi J; Yu W; Gu Y
Med Oncol; 2015 Mar; 32(3):69. PubMed ID: 25691294
[TBL] [Abstract][Full Text] [Related]
2. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
Lai IC; Shih PH; Yao CJ; Yeh CT; Wang-Peng J; Lui TN; Chuang SE; Hu TS; Lai TY; Lai GM
PLoS One; 2015; 10(3):e0114830. PubMed ID: 25763821
[TBL] [Abstract][Full Text] [Related]
3. Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria.
Itoh K; Ye P; Matsumiya T; Tanji K; Ozaki T
J Clin Biochem Nutr; 2015 Mar; 56(2):91-7. PubMed ID: 25759513
[TBL] [Abstract][Full Text] [Related]
4. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
van Thuijl HF; Mazor T; Johnson BE; Fouse SD; Aihara K; Hong C; Malmström A; Hallbeck M; Heimans JJ; Kloezeman JJ; Stenmark-Askmalm M; Lamfers ML; Saito N; Aburatani H; Mukasa A; Berger MS; Söderkvist P; Taylor BS; Molinaro AM; Wesseling P; Reijneveld JC; Chang SM; Ylstra B; Costello JF
Acta Neuropathol; 2015 Apr; 129(4):597-607. PubMed ID: 25724300
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.
Çıtışlı V; Dodurga Y; Eroğlu C; Seçme M; Avcı ÇB; Şatıroğlu-Tufan NL
Tumour Biol; 2015 Sep; 36(9):6765-72. PubMed ID: 25835972
[TBL] [Abstract][Full Text] [Related]
6. MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
Erice O; Smith MP; White R; Goicoechea I; Barriuso J; Jones C; Margison GP; Acosta JC; Wellbrock C; Arozarena I
Mol Cancer Ther; 2015 May; 14(5):1236-46. PubMed ID: 25777962
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels.
Liu M; Yao XD; Li W; Geng J; Yan Y; Che JP; Xu YF; Zheng JH
Biofactors; 2015; 41(1):52-7. PubMed ID: 25728635
[TBL] [Abstract][Full Text] [Related]
8. Regression of oxidative stress by targeting eNOS and Nrf2/ARE signaling: a guided drug target for cardiovascular diseases.
Ramprasath T; Vasudevan V; Sasikumar S; Puhari SS; Saso L; Selvam GS
Curr Top Med Chem; 2015; 15(9):857-71. PubMed ID: 25697563
[TBL] [Abstract][Full Text] [Related]
9. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Wang Q; Hu B; Hu X; Kim H; Squatrito M; Scarpace L; deCarvalho AC; Lyu S; Li P; Li Y; Barthel F; Cho HJ; Lin YH; Satani N; Martinez-Ledesma E; Zheng S; Chang E; Sauvé CG; Olar A; Lan ZD; Finocchiaro G; Phillips JJ; Berger MS; Gabrusiewicz KR; Wang G; Eskilsson E; Hu J; Mikkelsen T; DePinho RA; Muller F; Heimberger AB; Sulman EP; Nam DH; Verhaak RGW
Cancer Cell; 2017 Jul; 32(1):42-56.e6. PubMed ID: 28697342
[TBL] [Abstract][Full Text] [Related]
10. Epithelial MAPK signaling directs endothelial NRF2 signaling and IL-8 secretion in a tri-culture model of the alveolar-microvascular interface following diesel exhaust particulate (DEP) exposure.
Vitucci ECM; Simmons AE; Martin EM; McCullough SD
Part Fibre Toxicol; 2024 Mar; 21(1):15. PubMed ID: 38468337
[TBL] [Abstract][Full Text] [Related]
11. Water Extract of
Jeong Y; Lee SH; Lee J; Kim MS; Lee YG; Hwang JT; Choi SY; Yoon HG; Lim TG; Lee SH; Choi HK
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958893
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.
De Angelis M; Anichini G; Palamara AT; Nencioni L; Gori Savellini G
Virol J; 2023 Oct; 20(1):239. PubMed ID: 37853388
[TBL] [Abstract][Full Text] [Related]
13. Propofol Induces the Expression of Nrf2 and HO-1 in
Luo G; Ma B; Jiang Y; Lv H
Trop Med Infect Dis; 2023 Jun; 8(6):. PubMed ID: 37368724
[TBL] [Abstract][Full Text] [Related]
14. The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis.
Peng S; Shen L; Yu X; Zhang L; Xu K; Xia Y; Zha L; Wu J; Luo H
Front Immunol; 2023; 14():1200111. PubMed ID: 37359553
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil.
Almeida Lima K; Osawa IYA; Ramalho MCC; de Souza I; Guedes CB; Souza Filho CHD; Monteiro LKS; Latancia MT; Rocha CRR
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189700
[TBL] [Abstract][Full Text] [Related]
16. NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis.
Cirone M; D'Orazi G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614036
[TBL] [Abstract][Full Text] [Related]
17. The functional role of p38 MAPK pathway in malignant brain tumors.
Grave N; Scheffel TB; Cruz FF; Rockenbach L; Goettert MI; Laufer S; Morrone FB
Front Pharmacol; 2022; 13():975197. PubMed ID: 36299892
[TBL] [Abstract][Full Text] [Related]
18. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
20. Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review).
Li S; Xie X; Peng F; Du J; Peng C
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
